GeneDx Holdings (WGSWW) Short-term Investments (2023 - 2026)

GeneDx Holdings has disclosed Short-term Investments across 4 years of filings, most recently posting $76.8 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 29.11% year-over-year to $76.8 million; the TTM figure through Mar 2026 stood at $76.8 million (up 29.11% YoY), while the FY2025 annual figure was $66.3 million, up 18.42% from the prior year.
• Short-term Investments rose to $76.8 million in Q1 2026, from $66.3 million in the prior quarter.
• Over the last five years, Short-term Investments for WGSWW reached as high as $76.8 million in Q1 2026 and fell as low as $12.1 million in Q1 2023.
• The 4-year median for Short-term Investments is $57.3 million (2024), against an average of $48.8 million.
• Annual changes were most pronounced in 2024 — Short-term Investments surged 140.77% — and 2025, when it grew 0.93%.
• A 4-year view of Short-term Investments shows it stood at $30.5 million in 2023, then jumped by 83.72% to $56.0 million in 2024, then rose by 18.42% to $66.3 million in 2025, then grew by 15.8% to $76.8 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $76.8 million, $66.3 million, and $59.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.